Bold Therapeutics
BC - VancouverBiotechnology
Focus: Bold Therapeutics is an early-stage oncology biotech focused on small molecule therapies targeting cancer resistance, based in Vancouver, BC. The company is pre-revenue with a single Phase 1/2 program in colorectal cancer.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Bold Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Bold Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BOLD-100 +/- FOLFOX Chemotherapy
Colorectal CancerClinical Trials (1)
NCT04421820BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Phase 1/2Help build intelligence for Bold Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.